Form 4 holding
Director, 10%+ Owner
ArriVent Biopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 1,513,664
- Estimated value
- $5,524,874
- Report date
- 30 Jan 2024
- Price
- $3.65
- Ownership
- Indirect
Carl L. Gordon - Director, 10%+ Owner at ArriVent BioPharma, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- AVBP on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Carl L. Gordon since 18 Aug 2025
Reported holdings for Carl L. Gordon in ArriVent BioPharma, Inc.
Form 4 holding
Director, 10%+ Owner
ArriVent Biopharma, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 30 Jan 2024
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
ArriVent Biopharma, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 30 Jan 2024
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Carl L. Gordon in ArriVent BioPharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.